The vector of anti-CD56 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD56. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD56 antibody linked to CD28 signaling domains. And the vector product was designed for the treatment of relapsed refractory myeloma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-2-M312-2Z||Anti-CD56 scFv h(CD28-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC394||Lenti-CD56 CAR (scFv-CD4-FcεRIγ, N901) Viral Particle|
|CAR-T-2-M312-CZ||Anti-CD56 scFv h(b2c-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC389||Lenti-CD56 CAR (scFv-CD28, N901) Viral Particle|
|CAR-T-1-M312-Z||Anti-CD56 scFv h(CD3ζ) CART, pCDCAR1|
|CAR-T-3-M312-2XZ||Anti-CD56 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC395||Lenti-CD56 CAR (scFv-CD4-CD3ζ, N901) Viral Particle|
|VP-CAR-LC392||Lenti-CD56 CAR (scFv-CD28-FcεRIγ, N901) Viral Particle|
|VP-CAR-LC396||Lenti-CD56 CAR (scFv-CD8-CD3ζ, N901) Viral Particle|
|VP-CAR-LC393||Lenti-CD56 CAR (scFv-CD28-CD3ζ, N901) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved